| Cancer |
| AFP |
| CA 125 (Trademark of Fujirebio Diagnostic Inc.) |
| CA 15-3 (Trademark of Fujirebio Diagnostic Inc.) |
| CEA |
| PAP |
| PSA |
| |
| Fertility / Pregnancy |
| Estradiol |
| FSH |
| hCG |
| LH |
| Prolactin |
| |
| Fertility/Pregnancy-Congenital Diseases |
| CMV IgM |
| Rubella IgG 2.0 |
| Rubella IgM |
| TOXO IgG 2.0 |
| TOXO IgM |
| |
| Heart Disease |
| Stat CK-MB |
| |
|
| Hepatitis |
| CORE-M |
| HAVAB |
| HAVAB-M |
| |
| Kidney Disease |
| B2-Microglobulin |
| |
| Metabolic |
| Homocysteine |
| |
| Therapeutic Drug Monitoring |
| Digoxin |
| Theophylline |
| |
| Thyroid |
| Free T4 |
| T4 |
| Total T3 |
| Total T4 |
| T-Uptake |
| Ultrasensitive hTSH II |
| |
| Transplant |
| Tacrolimus II |
| |
|
